Antidepressant (AD) drugs are widely prescribed for the treatment of psychiatric disorders,
including depression and anxiety disorders. The continuous use of ADs causes significant …

Fluoxetine is one of the most studied and detected selective serotonin reuptake inhibitors in
the aquatic environment, found at concentrations ranging from ng/L to μg/L. Its presence in …

Antidepressants that enter receiving waters through final treated wastewater effluent have
exhibited relatively low acute toxicity in traditional fish tests at currently measured …

Antidepressants such as fluoxetine are frequently detected in estuaries and can have
profound effects on non-target organisms by interfering with the neural system and affecting …

Fluoxetine is a widely prescribed antidepressant that has been frequently detected in
aquatic environments and is associated with a series of neurological, behavioural and …

After application, antidepressants, like other pharmaceuticals, are excreted from human
body in their native form or as metabolites and enter the aquatic environment via different …

Antidepressant pharmaceuticals have been reported in wastewater effluent at the nanogram
to low microgram-per-liter range, and include bupropion (BUP), fluoxetine (FLX), sertraline …

Chemical pollution from pharmaceuticals is increasingly recognized as a major hazard to
the aquatic biota. Among the wide variety of pharmaceuticals, fluoxetine (FLX) is one of the …

Fluoxetine (FLX) is one of the main antidepressants used worldwide. After human use, FLX
enters the aquatic ecosystems, where it has commonly detected in the high ng/L …

Pharmaceuticals are increasingly being detected in aquatic ecosystems worldwide.
Particularly concerning are pharmaceutical pollutants that can adversely impact exposed …